TRACON Pharmaceuticals Inc (TCON): It’s an event-driven trial where PFS is...

Send PM Follow Ignore

Followers	826
Posts	119567
Boards Moderated	14
Alias Born	09/05/2002

DewDiligence

Re: randychub post# 33

Wednesday, 11/15/2017 12:57:49 PM

Wednesday, November 15, 2017 12:57:49 PM

It’s an event-driven trial where PFS is the primary endpoint; clinicaltrials.gov shows Sep 2018 as the estimated date for the primary analysis:

https://www.clinicaltrials.gov/ct2/show/NCT02979899

p.s. Pazopanib = Votrient (a GSK drug).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent TCON News

Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/07/2024 10:03:57 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/05/2024 10:00:35 PM
TRACON to Report Fourth Quarter and Year-End 2023 Financial Results and Provide Corporate Update on March 5, 2024 • GlobeNewswire Inc. • 02/28/2024 09:02:00 PM
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:31:59 PM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/09/2024 09:05:32 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2023 10:00:08 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/08/2023 10:00:10 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2023 01:05:40 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 10:00:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/06/2023 09:00:09 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2023 12:10:44 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 08:11:15 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 09:01:24 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 08:12:31 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/07/2023 09:02:56 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 07/25/2023 09:19:54 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/11/2023 12:08:13 PM

More TCON News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover